50 related articles for article (PubMed ID: 12447665)
21. X-linked lymphoproliferative disease: three atypical cases.
Nistala K; Gilmour KC; Cranston T; Davies EG; Goldblatt D; Gaspar HB; Jones AM
Clin Exp Immunol; 2001 Oct; 126(1):126-30. PubMed ID: 11678908
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of SAP gene defects in male patients diagnosed with common variable immunodeficiency.
Eastwood D; Gilmour KC; Nistala K; Meaney C; Chapel H; Sherrell Z; Webster AD; Davies EG; Jones A; Gaspar HB
Clin Exp Immunol; 2004 Sep; 137(3):584-8. PubMed ID: 15320910
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis of X-linked lymphoproliferative disease by analysis of SLAM-associated protein expression.
Gilmour KC; Cranston T; Jones A; Davies EG; Goldblatt D; Thrasher A; Kinnon C; Nichols KE; Gaspar HB
Eur J Immunol; 2000 Jun; 30(6):1691-7. PubMed ID: 10898506
[TBL] [Abstract][Full Text] [Related]
24. Mutations of the X-linked lymphoproliferative disease gene SH2D1A mimicking common variable immunodeficiency.
Soresina A; Lougaris V; Giliani S; Cardinale F; Armenio L; Cattalini M; Notarangelo LD; Plebani A
Eur J Pediatr; 2002 Dec; 161(12):656-9. PubMed ID: 12447665
[TBL] [Abstract][Full Text] [Related]
25. X-linked lymphoproliferative disease: a progressive immunodeficiency.
Morra M; Howie D; Grande MS; Sayos J; Wang N; Wu C; Engel P; Terhorst C
Annu Rev Immunol; 2001; 19():657-82. PubMed ID: 11244050
[TBL] [Abstract][Full Text] [Related]
26. Variable clinical phenotypes of X-linked lymphoproliferative syndrome in China: Report of five cases with three novel mutations and review of the literature.
Jin YY; Zhou W; Tian ZQ; Chen TX
Hum Immunol; 2016 Aug; 77(8):658-666. PubMed ID: 27288720
[TBL] [Abstract][Full Text] [Related]
27. [X-linked lymphoproliferative syndrome, EBV virus infection and defects in cytotoxicity lymphocyte regulation].
Malbrán A; Belmonte L; Ruibal-Ares B; Baré P; Bracco MM
Medicina (B Aires); 2003; 63(1):70-6. PubMed ID: 12673966
[TBL] [Abstract][Full Text] [Related]
28. Pathogenesis and diagnosis of X-linked lymphoproliferative disease.
Gilmour KC; Gaspar HB
Expert Rev Mol Diagn; 2003 Sep; 3(5):549-61. PubMed ID: 14510176
[TBL] [Abstract][Full Text] [Related]
29. The abnormal gene in X-linked lymphoproliferative syndrome.
Sullivan JL
Curr Opin Immunol; 1999 Aug; 11(4):431-4. PubMed ID: 10448142
[TBL] [Abstract][Full Text] [Related]
30. [X-linked lymphoproliferative syndrome].
Kanegane H
Nihon Rinsho Meneki Gakkai Kaishi; 2002 Feb; 25(1):129-34. PubMed ID: 11963172
[No Abstract] [Full Text] [Related]
31. Cellular and molecular pathogenesis of X-linked lymphoproliferative disease.
Moretta A; Bottino C; Parolini S; Moretta L; Biassoni R; Notarangelo LD
Curr Opin Allergy Clin Immunol; 2001 Dec; 1(6):513-7. PubMed ID: 11964734
[TBL] [Abstract][Full Text] [Related]
32. X-linked lymphoproliferative disease: clinical, diagnostic and molecular perspective.
Gaspar HB; Sharifi R; Gilmour KC; Thrasher AJ
Br J Haematol; 2002 Dec; 119(3):585-95. PubMed ID: 12437631
[No Abstract] [Full Text] [Related]
33. [X-linked lymphoproliferative syndrome (XLP)].
Kawa K
Ryoikibetsu Shokogun Shirizu; 2000; (32):528-30. PubMed ID: 11212794
[No Abstract] [Full Text] [Related]
34. A unique clinical presentation of X-linked lymphoproliferative syndrome with a novel mutation in SH2D1A and review of the literature.
Eckrich MJ; Yang E; Domm J; Ho R; Calder C; Manes B; Bleesing J; Frangoul H
J Pediatr Hematol Oncol; 2011 Jan; 33(1):e39-42. PubMed ID: 20975587
[TBL] [Abstract][Full Text] [Related]
35. X-linked lymphoproliferative syndrome.
Nelson DL; Terhorst C
Clin Exp Immunol; 2000 Dec; 122(3):291-5. PubMed ID: 11122230
[No Abstract] [Full Text] [Related]
36. X-linked lymphoproliferative disease (XLP): a model of impaired anti-viral, anti-tumor and humoral immune responses.
Bassiri H; Janice Yeo WC; Rothman J; Koretzky GA; Nichols KE
Immunol Res; 2008; 42(1-3):145-59. PubMed ID: 18815745
[TBL] [Abstract][Full Text] [Related]
37. Natural killer T cells and X-linked lymphoproliferative syndrome.
Latour S
Curr Opin Allergy Clin Immunol; 2007 Dec; 7(6):510-4. PubMed ID: 17989527
[TBL] [Abstract][Full Text] [Related]
38. [Lymphoproliferative disorders caused by hereditary genetic defects].
Kanegane H; Miyawaki T
Nihon Rinsho Meneki Gakkai Kaishi; 2003 Dec; 26(6):311-22. PubMed ID: 14752931
[No Abstract] [Full Text] [Related]
39. Genetics of common variable immunodeficiency: role of transmembrane activator and calcium modulator and cyclophilin ligand interactor.
Sathkumara HD; De Silva NR; Handunnetti S; De Silva AD
Int J Immunogenet; 2015 Aug; 42(4):239-53. PubMed ID: 26096648
[TBL] [Abstract][Full Text] [Related]
40. The SAP and SLAM families in immune responses and X-linked lymphoproliferative disease.
Engel P; Eck MJ; Terhorst C
Nat Rev Immunol; 2003 Oct; 3(10):813-21. PubMed ID: 14523387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
